Insights from 2024 ASCO® GI Annual Meeting


 

ASCO® GI 2024 Insights: "FRESCO-2 trial - Quality-Adjusted Time Without Symptoms of Disease or Toxicity Analysis of Fruquintinib + BSC Compared With Placebo + BSC in mCRC"

150 views
January 31, 2024
Comments 0
Login to view comments. Click here to Login